Covered recipient · General Payments record

ANCA ZEGREAN

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI: 1508009416
CMS profile: 1275965
Location: LIBERTYVILLE, IL

General Payments · PY2018–2024

$5,976.23

Reported across 250 records
CMS publication 2026-01-23

Latest program year · PY2024

$2,010.52

73 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Food and Beverage	$1,983.58	70
Education	$26.94	3

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
Amgen Inc.	$550.75	19
Acerta Pharma LLC	$238.47	7
Mallinckrodt Hospital Products Inc.	$202.15	9
Lilly USA, LLC	$174.79	7
Ardelyx, Inc.	$157.06	3
Aurinia Pharma U.S., Inc.	$90.31	4
Bayer HealthCare Pharmaceuticals Inc.	$79.72	3
CALLIDITAS THERAPEUTICS US INC.	$75.28	3
NOVARTIS PHARMACEUTICALS CORPORATION	$74.31	3
Boehringer Ingelheim Pharmaceuticals, Inc.	$73.50	3
Otsuka America Pharmaceutical, Inc.	$53.22	2
Relypsa, Inc.	$43.45	2
Ultragenyx Pharmaceutical Inc.	$39.52	2
Retrophin, Inc.	$34.26	1
Daiichi Sankyo Inc.	$32.42	1
Otsuka Pharmaceutical Development & Commercialization, Inc.	$28.58	1
Takeda Pharmaceuticals U.S.A., Inc.	$24.11	1
Veloxis Pharmaceuticals, Inc.	$20.06	1
Alnylam Pharmaceuticals Inc.	$18.56	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2018	$653.23	35
PY2019	$406.37	18
PY2020	$247.32	14
PY2021	$506.13	27
PY2022	$858.97	32
PY2023	$1,293.69	51
PY2024	$2,010.52	73

Payment records · PY2024 (73)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018 2019 2020 2021 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
Alnylam Pharmaceuticals Inc.	$18.56	05/23/2024	Food and Beverage	Undisputed	01/23/2026	1125826971	CMS
Amgen Inc.	$20.59	02/06/2024	Food and Beverage	Undisputed	01/23/2026	1117422066	CMS
Amgen Inc.	$25.93	02/08/2024	Food and Beverage	Undisputed	01/23/2026	1111746526	CMS
Amgen Inc.	$17.17	03/14/2024	Food and Beverage	Undisputed	01/23/2026	1117422068	CMS
Amgen Inc.	$10.68	03/21/2024	Education	Undisputed	01/23/2026	1111746510	CMS
Amgen Inc.	$24.94	03/25/2024	Food and Beverage	Undisputed	01/23/2026	1111746508	CMS
Amgen Inc.	$30.02	04/16/2024	Food and Beverage	Undisputed	01/23/2026	1111746528	CMS
Amgen Inc.	$121.83	04/18/2024	Food and Beverage	Undisputed	01/23/2026	1117422072	CMS
Amgen Inc.	$19.90	04/25/2024	Food and Beverage	Undisputed	01/23/2026	1117422070	CMS
Amgen Inc.	$22.86	05/02/2024	Food and Beverage	Undisputed	01/23/2026	1111746512	CMS
Amgen Inc.	$10.68	05/02/2024	Education	Undisputed	01/23/2026	1111746514	CMS
Amgen Inc.	$5.58	05/02/2024	Education	Undisputed	01/23/2026	1111746516	CMS
Amgen Inc.	$5.71	07/17/2024	Food and Beverage	Undisputed	01/23/2026	1111746518	CMS
Amgen Inc.	$8.57	08/22/2024	Food and Beverage	Undisputed	01/23/2026	1111746520	CMS
Amgen Inc.	$19.77	08/22/2024	Food and Beverage	Undisputed	01/23/2026	1117422074	CMS
Amgen Inc.	$7.13	09/03/2024	Food and Beverage	Undisputed	01/23/2026	1111746522	CMS
Amgen Inc.	$23.95	09/05/2024	Food and Beverage	Undisputed	01/23/2026	1111746530	CMS
Amgen Inc.	$141.09	09/26/2024	Food and Beverage	Undisputed	01/23/2026	1111746532	CMS
Amgen Inc.	$18.54	10/24/2024	Food and Beverage	Undisputed	01/23/2026	1111746524	CMS
Amgen Inc.	$15.81	10/29/2024	Food and Beverage	Undisputed	01/23/2026	1117422076	CMS
Ardelyx, Inc.	$19.88	06/04/2024	Food and Beverage	Undisputed	01/23/2026	1146715605	CMS
Ardelyx, Inc.	$121.86	07/17/2024	Food and Beverage	Undisputed	01/23/2026	1146715607	CMS
Ardelyx, Inc.	$15.32	08/29/2024	Food and Beverage	Undisputed	01/23/2026	1146715609	CMS
AstraZeneca Pharmaceuticals LP	$110.71	01/09/2024	Food and Beverage	Undisputed	01/23/2026	1104653677	CMS
AstraZeneca Pharmaceuticals LP	$14.75	03/08/2024	Food and Beverage	Undisputed	01/23/2026	1105339012	CMS
AstraZeneca Pharmaceuticals LP	$23.69	04/02/2024	Food and Beverage	Undisputed	01/23/2026	1104589684	CMS
AstraZeneca Pharmaceuticals LP	$15.42	04/19/2024	Food and Beverage	Undisputed	01/23/2026	1104321822	CMS
AstraZeneca Pharmaceuticals LP	$27.13	08/01/2024	Food and Beverage	Undisputed	01/23/2026	1105351944	CMS
AstraZeneca Pharmaceuticals LP	$30.19	08/13/2024	Food and Beverage	Undisputed	01/23/2026	1104547584	CMS
AstraZeneca Pharmaceuticals LP	$16.58	10/08/2024	Food and Beverage	Undisputed	01/23/2026	1104264979	CMS
Aurinia Pharma U.S., Inc.	$19.88	03/11/2024	Food and Beverage	Undisputed	01/23/2026	1150694890	CMS
Aurinia Pharma U.S., Inc.	$21.78	05/14/2024	Food and Beverage	Undisputed	01/23/2026	1150694892	CMS
Aurinia Pharma U.S., Inc.	$24.55	06/13/2024	Food and Beverage	Undisputed	01/23/2026	1150694894	CMS
Aurinia Pharma U.S., Inc.	$24.10	08/27/2024	Food and Beverage	Undisputed	01/23/2026	1150694896	CMS
Bayer Healthcare Pharmaceuticals Inc.	$22.85	04/11/2024	Food and Beverage	Undisputed	01/23/2026	1086188346	CMS
Bayer Healthcare Pharmaceuticals Inc.	$24.43	05/16/2024	Food and Beverage	Undisputed	01/23/2026	1086197600	CMS
Bayer Healthcare Pharmaceuticals Inc.	$32.44	07/03/2024	Food and Beverage	Undisputed	01/23/2026	1086213613	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$23.41	01/17/2024	Food and Beverage	Undisputed	01/23/2026	1118035521	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$29.47	05/09/2024	Food and Beverage	Undisputed	01/23/2026	1118035523	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$20.62	09/12/2024	Food and Beverage	Undisputed	01/23/2026	1118035519	CMS
CALLIDITAS THERAPEUTICS US INC.	$29.15	09/27/2024	Food and Beverage	Undisputed	01/23/2026	1141523591	CMS
CALLIDITAS THERAPEUTICS US INC.	$23.15	11/05/2024	Food and Beverage	Undisputed	01/23/2026	1141526420	CMS
CALLIDITAS THERAPEUTICS US INC.	$22.98	12/17/2024	Food and Beverage	Undisputed	01/23/2026	1141529805	CMS
Daiichi Sankyo Inc.	$32.42	11/07/2024	Food and Beverage	Undisputed	01/23/2026	1089501520	CMS
Lilly USA, LLC	$26.00	02/01/2024	Food and Beverage	Undisputed	01/23/2026	1136031140	CMS
Lilly USA, LLC	$26.98	03/14/2024	Food and Beverage	Undisputed	01/23/2026	1136046987	CMS
Lilly USA, LLC	$20.14	06/24/2024	Food and Beverage	Undisputed	01/23/2026	1135998283	CMS
Lilly USA, LLC	$28.23	07/29/2024	Food and Beverage	Undisputed	01/23/2026	1136034374	CMS
Lilly USA, LLC	$26.82	10/25/2024	Food and Beverage	Undisputed	01/23/2026	1136034376	CMS
Lilly USA, LLC	$22.65	11/06/2024	Food and Beverage	Undisputed	01/23/2026	1136039825	CMS
Lilly USA, LLC	$23.97	12/16/2024	Food and Beverage	Undisputed	01/23/2026	1136034372	CMS
Mallinckrodt Hospital Products Inc.	$32.97	01/12/2024	Food and Beverage	Undisputed	01/23/2026	1145156118	CMS
Mallinckrodt Hospital Products Inc.	$15.31	03/19/2024	Food and Beverage	Undisputed	01/23/2026	1145156122	CMS
Mallinckrodt Hospital Products Inc.	$22.95	04/30/2024	Food and Beverage	Undisputed	01/23/2026	1145156126	CMS
Mallinckrodt Hospital Products Inc.	$23.68	05/28/2024	Food and Beverage	Undisputed	01/23/2026	1145156131	CMS
Mallinckrodt Hospital Products Inc.	$1.02	08/20/2024	Food and Beverage	Undisputed	01/23/2026	1145156135	CMS
Mallinckrodt Hospital Products Inc.	$30.48	08/20/2024	Food and Beverage	Undisputed	01/23/2026	1145156139	CMS
Mallinckrodt Hospital Products Inc.	$22.22	08/28/2024	Food and Beverage	Undisputed	01/23/2026	1145156143	CMS
Mallinckrodt Hospital Products Inc.	$21.15	11/19/2024	Food and Beverage	Undisputed	01/23/2026	1145156147	CMS
Mallinckrodt Hospital Products Inc.	$32.37	12/18/2024	Food and Beverage	Undisputed	01/23/2026	1145156152	CMS
Novartis Pharmaceuticals Corporation	$30.04	04/09/2024	Food and Beverage	Undisputed	01/23/2026	1087426668	CMS
Novartis Pharmaceuticals Corporation	$24.72	09/03/2024	Food and Beverage	Undisputed	01/23/2026	1087426680	CMS
Novartis Pharmaceuticals Corporation	$19.55	12/05/2024	Food and Beverage	Undisputed	01/23/2026	1087426684	CMS
Otsuka America Pharmaceutical, Inc.	$25.72	02/22/2024	Food and Beverage	Undisputed	01/23/2026	1119009047	CMS
Otsuka America Pharmaceutical, Inc.	$27.50	09/24/2024	Food and Beverage	Undisputed	01/23/2026	1119009049	CMS
Otsuka Pharmaceutical Development & Commercialization, Inc.	$28.58	05/21/2024	Food and Beverage	Undisputed	01/23/2026	1118840501	CMS
Takeda Pharmaceuticals U.S.A., Inc.	$24.11	10/10/2024	Food and Beverage	Undisputed	01/23/2026	1137702546	CMS
Travere Therapeutics, Inc.	$34.26	11/12/2024	Food and Beverage	Undisputed	01/23/2026	1149927208	CMS
Ultragenyx Pharmaceutical Inc.	$20.43	01/25/2024	Food and Beverage	Undisputed	01/23/2026	1153281336	CMS
Ultragenyx Pharmaceutical Inc.	$19.09	08/20/2024	Food and Beverage	Undisputed	01/23/2026	1153282700	CMS
Veloxis Pharmaceuticals, Inc.	$20.06	12/03/2024	Food and Beverage	Undisputed	01/23/2026	1147093980	CMS
Vifor Pharma, Inc.	$18.45	10/23/2024	Food and Beverage	Undisputed	01/23/2026	1124059178	CMS
Vifor Pharma, Inc.	$25.00	11/21/2024	Food and Beverage	Undisputed	01/23/2026	1124059575	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.